tiprankstipranks
Cano Health (CANOQ)
OTHER OTC:CANOQ
US Market

Cano Health (CANOQ) Stock Forecast & Price Target

248 Followers
See the Price Targets and Ratings of:

CANOQ Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Cano
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CANOQ Stock 12 Month Forecast

There Are No Analyst Ratings for CANOQ In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

CANOQ Financial Forecast

CANOQ Earnings Forecast

The previous quarter’s earnings for CANOQ were -$81.27.
The previous quarter’s earnings for CANOQ were -$81.27.

CANOQ Sales Forecast

The previous quarter’s earnings for CANOQ were $716.03M.
The previous quarter’s earnings for CANOQ were $716.03M.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial
Hold
Reiterated
01/04/24
Cano Health (CANO) Receives a Hold from Truist Financial
Barclays
$3.75
Sell
1342.31%
Upside
Downgraded
11/17/23
Cano Health downgraded to Sell from Neutral at UBSCano Health downgraded to Sell from Neutral at UBS
Piper Sandler
$50.00
Sell
19130.77%
Upside
Reiterated
09/28/23
Analysts Conflicted on These Healthcare Names: Gritstone Oncology (NASDAQ: GRTS) and Cano Health (NYSE: CANO)
Citi
$80.00
Hold
30669.23%
Upside
Reiterated
09/26/23
Analysts' Opinions Are Mixed on These Healthcare Stocks: Inozyme Pharma (NASDAQ: INZY), Ionis Pharmaceuticals (NASDAQ: IONS) and Cano Health (NYSE: CANO)
Bank of America Securities
$25.00
Sell
9515.38%
Upside
Reiterated
09/05/23
Cano Health (CANO) PT Lowered to $0.25 at BofA SecuritiesBofA Securities analyst Adam Ron lowered the price target on Cano Health (NYSE: CANO) to $0.25 (from $1.00) while maintaining a Underperform rating.
TD Cowen
$50.00
Hold
19130.77%
Upside
Reiterated
08/15/23
Cano Health (CANO) PT Lowered to $0.50 at TD CowenTD Cowen analyst Gary Taylor lowered the price target on Cano Health (NYSE: CANO) to $0.50 (from $3.00) while maintaining a Market Perform rating.
UBS
$50.00
Hold
19130.77%
Upside
Reiterated
08/14/23
Cano Health (CANO) PT Lowered to $0.50 at Credit SuisseCredit Suisse analyst A.J. Rice lowered the price target on Cano Health (NYSE: CANO) to $0.50 (from $2.50) while maintaining a Neutral rating.
Jefferies
$55.00
Hold
21053.85%
Upside
Downgraded
08/11/23
Cano Health downgraded to Hold from Buy at JefferiesCano Health downgraded to Hold from Buy at Jefferies

Best Analysts Covering Cano Health

Which Analyst Should I Follow If I Want to Buy CANOQ and Sell After:
1 Month
Adam RonBank of America Securities
Success Rate
4/6 ratings generated profit
67%
Average Return
+9.77%
reiterated a sell rating 8 months ago
Copying Adam Ron's trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +9.77% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Jessica TassanPiper Sandler
Success Rate
3/5 ratings generated profit
60%
Average Return
+36.92%
reiterated a sell rating 7 months ago
Copying Jessica Tassan's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +36.92% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Jessica TassanPiper Sandler
Success Rate
5/5 ratings generated profit
100%
Average Return
+82.46%
reiterated a sell rating 7 months ago
Copying Jessica Tassan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +82.46% per trade.
2 Years
Jessica TassanPiper Sandler
Success Rate
5/5 ratings generated profit
100%
Average Return
+99.68%
reiterated a sell rating 7 months ago
Copying Jessica Tassan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +99.68% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CANOQ Analyst Recommendation Trends

Rating
Aug 23
Sep 23
Oct 23
Nov 23
Jan 24
Strong Buy
1
1
0
0
0
Buy
0
0
0
0
0
Hold
9
9
8
6
5
Sell
1
3
3
2
0
Strong Sell
0
0
0
1
1
total
11
13
11
9
6
In the current month, CANOQ has received 0 Buy Ratings, 5 Hold Ratings, and 1 Sell Ratings. CANOQ average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

CANOQ Stock Forecast FAQ

What is CANOQ’s average 12-month price target, according to analysts?
Currently, no data Available
What is CANOQ’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CANOQ, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is CANOQ a Buy, Sell or Hold?
      Currently, no data Available
      What is Cano Health’s price target?
      Currently, no data Available
      What do analysts say about Cano Health?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of CANOQ?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis